DGCR8 and cardiac hypertrophy: In bladder cancer and cardiac hypertrophy models, METTL3 exerts oncogenic and pro-fibrotic effects by facilitating DGCR8-mediated maturation of pri-miR-221/222 in an m6A-dependent manner (35, 36).